Skip to main content

Peer Review reports

From: Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease

Original Submission
7 Mar 2011 Submitted Original manuscript
19 Apr 2011 Reviewed Reviewer Report - Laszlo Vecsei
6 Jun 2011 Reviewed Reviewer Report - Lawrence Elmer
16 Jun 2011 Reviewed Reviewer Report - Oren Cohen
21 Jul 2011 Author responded Author comments - Matthias Löhle
Resubmission - Version 2
21 Jul 2011 Submitted Manuscript version 2
25 Jul 2011 Reviewed Reviewer Report - Laszlo Vecsei
25 Jul 2011 Reviewed Reviewer Report - Oren Cohen
12 Aug 2011 Reviewed Reviewer Report - Lawrence Elmer
25 Aug 2011 Author responded Author comments - Matthias Löhle
Resubmission - Version 3
25 Aug 2011 Submitted Manuscript version 3
16 Sep 2011 Author responded Author comments - Matthias Löhle
Resubmission - Version 4
16 Sep 2011 Submitted Manuscript version 4
Publishing
22 Sep 2011 Editorially accepted
22 Sep 2011 Article published 10.1186/1471-2377-11-112

You can find further information about peer review here.

Back to article page